Retinopathy News and Research

RSS

Scientists develop new method to reconstruct biological processes using image data

Researchers at the Helmholtz Zentrum München have developed a new method for reconstructing continuous biological processes, such as disease progression, using image data. The study was published in ‘Nature Communications’.

11 Sep 2017

Study investigates feasibility and accuracy of CCHD screening with new Masimo iSpO2

Masimo announced today the findings of a recently published study in which researchers in Maastricht, The Netherlands evaluated the performance of Masimo iSpO2 Rx in screening newborns for critical congenital heart disease (CCHD).

5 Sep 2017

New diabetes eye supplement to be showcased at Expopharm 2017

A pioneering food supplement that protects the eye from damage caused by diabetes will be showcased at Expopharm 2017 - Europe’s leading pharmaceutical exhibition.

31 Aug 2017

Second Sight achieves milestone with conditional FDA approval to start Orion feasibility clinical trial

Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.

29 Aug 2017

Medical care in California's NICUs influenced by infants' racial and ethnic identities

Infants' racial and ethnic identities influence the quality of medical care they receive in California's neonatal intensive care units, a study from the Stanford University School of Medicine has found.

28 Aug 2017

Vision research using donated human tissue could help millions suffering from diabetic eye disease

When Coleen Anegon's husband, Tim, received a liver donation as a patient at the University of Michigan in 2014, she immediately felt indebted to the donor who gave him the gift of life.

26 Aug 2017

Bionic vision restoration: could future technologies restore sight?

The brain is very plastic, which means that the brain is able to adapt to new signals. In the case of bionic vision restoration, the photoreceptors have died, the brain is not receiving anything biologically, and you are going to then send something which is artificial, prosthetic, and has been created outside the body.

21 Aug 2017

Eye surgeon offers tips for safe viewing of solar eclipse

On Monday, Aug. 21, a total solar eclipse will offer a rare -; although brief -; sight to millions when the sun disappears fully behind the moon. An otherwise bright summer sky will give way to total darkness.

16 Aug 2017

Immunotherapy shows promise in treatment of Type 1 diabetes

Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body’s own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

10 Aug 2017

Improper viewing of solar eclipse may cause irreversible damage to vision, warns Loyola ophthalmologist

On Monday, August 21, residents of North America will be treated to a total solar eclipse – the first time the contiguous U.S. will witness a total solar eclipse since 1979.

10 Aug 2017

SLUCare retina specialist shares tips to protect eyes while viewing historic eclipse

With the first total eclipse of the sun in four decades less than a month away, the buzz is growing as schools announce they will close for the day, social gatherings are being planned and people are deciding on their "must see" viewing location.

4 Aug 2017

UAB specialists offer tips on eye safety while viewing the eclipse

Watching the captivating sight of the moon's passing between the sun and Earth, where the moon fully or partially covers the sun, could cause serious and potentially long-term harm to the eye if not viewed properly.

3 Aug 2017

Quantel Medical wins FDA approval for innovative Easyret photocoagulator

Quantel Medical today announced that it has received approval from the U.S. Food and Drug Administration on July 25, 2017 for the innovative new Easyret fully integrated 577nm yellow photocoagulator, which is used to treat certain forms of macular edema and peripheral retinal pathologies.

27 Jul 2017

Researchers present novel gene-editing technique to prevent retinal angiogenesis

A research team from the Schepens Eye Research Institute of Massachusetts Eye and Ear has successfully prevented mice from developing angiogenesis of the retina--the sensory tissue at the back of the eye--using gene-editing techniques with CRISPR-Cas9.

25 Jul 2017

Safe ways to watch a solar eclipse

A solar eclipse will be visible across North America for 2 to 3 hours on Monday, August 21, 2017. Watching the moon slowly block out the sun is a rare opportunity but should be attempted with caution.

24 Jul 2017

Low vitamin D may affect recovery of injured corneas

Injury or disease in combination with too little vitamin D can be bad for the window to your eyes. The three-layer, transparent cornea at the front of the eyes focuses the light coming in. But its prominent position also puts it at risk for injury from an errant mascara wand or over-prodding finger or a car accident.

24 Jul 2017

Patients with Type 2 diabetes and OSA found to be at greater risk of developing diabetic retinopathy

Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average period of less than four years.

4 Jul 2017

Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema

Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion, according to a clinical trial funded by the National Eye Institute, part of the National Institutes of Health.

10 May 2017

Researchers find way to use artificial intelligence to combat diabetic retinopathy

Researchers from the Byers Eye Institute at Stanford University have found a way to use artificial intelligence to fight a complication of diabetes that affects the eyes. This advance has the potential to reduce the worldwide rate of vision loss due to diabetes.

28 Apr 2017

Glycated CD59 identified as novel biomarker for screening and diagnosis of gestational diabetes

Mellitus, LLC today reported the publication of results from a prospective, investigator-initiated study conducted at Brigham and Women's Hospital demonstrating the potential clinical utility of glycated CD59 (GCD59) as a novel biomarker for the screening and diagnosis of gestational diabetes mellitus.